PreferredStockChannel
Fortress Biotech Inc (FBIO)

Fortress Biotech is a biopharmaceutical company. Through its partner company, Co. markets the following dermatology products: Ximino®, which treats only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox®, which is used as adjunctive therapy for severe acne; Exelderm®, which treats tinea infection; Ceracade®, which is used to treat dry skin conditions and to manage and relieve the burning and itching associated with various types of dermatitis and radiation dermatitis; ad Luxamend®, which is used for the dressing and management of superficial wounds, minor abrasions, dermal ulcers, donor sites, first- and second-degree burns, and radiation dermatitis.

Preferred: FBIOP

Name: 
Fortress Biotech Inc
Website: 
www.fortressbiotech.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding FBIO: 
4 (see which ones)
Total Market Value Held by ETFs: 
$5,309,028
Total Market Capitalization: 
$222,000,000
% of Market Cap. Held by ETFs: 
2.39%
Quotes delayed 20 minutes


Strong Buy (4.00 out of 4)
94th percentile
(ranked higher than approx. 94% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com
Top Ten Highest Yielding Preferred Stocks
Feel-Good Income: Socially Responsible Preferreds
Dividend Channel's 25 S.A.F.E. Dividend Stocks
Increasing Payments For Decades

Safer than S.A.F.E: Preferreds of Dividend Channel's
S.A.F.E. Dividend Stocks

Recent Preferred Stock Offerings
Preferred Stocks of Dow Components
Preferred Stocks of S&P 500 Components
Preferred Stocks By Industry
Preferred Stocks Where Insiders Are Buying The Common
High Yield Preferred Stocks
Preferreds Trading At Premiums To Liquidation Preference
Preferreds Trading At Discounts To Liquidation Preference
The Top 10 DividendRank'ed U.S. Stocks
The Top 10 DividendRank'ed Canadian Stocks
Top 25 Broker Analyst Picks of the S&P 500
Stock market game

Fortress Biotech Inc (FBIO) Information Page | Preferred Stock Channel | www.PreferredStockChannel.com

Copyright © 2010 - 2020, All Rights Reserved Nothing in Preferred Stock Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact Preferred Stock Channel; Meet Our Editorial Staff.